Skip to Main Content

NISH (NITAG Support Hub) 12: Whole-cell (wP) Hexavalent vaccine: Keywords and phrases applied for the EtR domains

This Library Guide is a collection of useful documents & evidence on the safety, efficacy, effectiveness and impact of the whole-cell (wP) Hexavalent vaccine to support NITAG members and other policy makers throughout Africa with making evidence-based r

Disclaimer

The search terms, keywords, and phrases used for each EtR domain (1–7) represent a basic and systematic approach. However, the search may not have captured all relevant articles, reports, or publications available in the literature

Keywords and phrases

Domain 1:

Whole Cell (wP) Hexavalent vaccine and “disease burden” OR epidemiology OR incidence OR cases OR hospitalization OR case fatality OR  “clinical characteristics” OR “cost of health care” OR “alternative prevention”

Domain 2:

Whole Cell (wP) Hexavalent vaccine and “benefits and harms” OR safety OR efficacy OR effectiveness OR “adverse events”

Domain 3:

Whole Cell (wP) Hexavalent vaccine and “values and preferences” OR demand

Domain 4:

Whole Cell (wP) Hexavalent and “availability of vaccine” OR “resource use” OR cost-effectiveness

Domain 5:

Whole Cell (wP) Hexavalent vaccine and “health equity” OR  “ethical or legal implication”

Domain 6:

Whole Cell (wP) Hexavalent vaccine and “acceptability of intervention” OR “acceptance of intervention”

Domain 7:

Whole Cell (wP) Hexavalent vaccine and feasibility OR “successful implementation” OR “financial barriers” OR “vaccine supply” OR “vaccine use”